DE69212879D1 - Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren - Google Patents
Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von GallensäurenInfo
- Publication number
- DE69212879D1 DE69212879D1 DE69212879T DE69212879T DE69212879D1 DE 69212879 D1 DE69212879 D1 DE 69212879D1 DE 69212879 T DE69212879 T DE 69212879T DE 69212879 T DE69212879 T DE 69212879T DE 69212879 D1 DE69212879 D1 DE 69212879D1
- Authority
- DE
- Germany
- Prior art keywords
- oral administration
- pharmaceutical formulations
- gastric juice
- bile acids
- stable pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBO910113A IT1245890B (it) | 1991-04-12 | 1991-04-12 | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69212879D1 true DE69212879D1 (de) | 1996-09-26 |
DE69212879T2 DE69212879T2 (de) | 1997-01-23 |
Family
ID=11337390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69212879T Expired - Fee Related DE69212879T2 (de) | 1991-04-12 | 1992-04-02 | Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren |
Country Status (8)
Country | Link |
---|---|
US (1) | US5380533A (de) |
EP (1) | EP0509335B1 (de) |
JP (1) | JP2509045B2 (de) |
KR (1) | KR970005176B1 (de) |
CA (1) | CA2065773C (de) |
DE (1) | DE69212879T2 (de) |
ES (1) | ES2090395T3 (de) |
IT (1) | IT1245890B (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262172A (en) * | 1992-06-19 | 1993-11-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing buffered bile acids |
GB9417524D0 (en) * | 1994-08-31 | 1994-10-19 | Cortecs Ltd | Pharmaceutical compositions |
KR100578669B1 (ko) * | 1997-05-29 | 2006-12-07 | 동아제약주식회사 | 우르소데옥시콜린산을함유하는투명연질캅셀 |
DE29717252U1 (de) * | 1997-09-26 | 1998-02-19 | Dr. Falk Pharma GmbH, 79108 Freiburg | Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen |
US7772220B2 (en) * | 2004-10-15 | 2010-08-10 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
US20050158408A1 (en) * | 1998-07-24 | 2005-07-21 | Yoo Seo H. | Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof |
US7303768B2 (en) * | 1998-07-24 | 2007-12-04 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
EP1113785B1 (de) | 1998-07-24 | 2005-04-13 | Seo Hong Yoo | Klare wässrige lösungen enthaltend gallensäuren |
US20020068365A1 (en) * | 1998-07-28 | 2002-06-06 | Eric H. Kuhrts | Controlled release nitric oxide producing agents |
DE19906290A1 (de) * | 1999-02-15 | 2000-08-17 | Falk Pharma Gmbh | Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs |
CA2406930C (en) * | 2000-02-04 | 2011-02-15 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
CA2406067A1 (en) * | 2000-04-19 | 2001-11-01 | Thomas Julius Borody | Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders |
US7166234B1 (en) * | 2000-10-26 | 2007-01-23 | Integrated Biomedical Technology, Inc. | Dialdehyde assay |
KR100368936B1 (ko) * | 2000-10-04 | 2003-01-24 | 주식회사 대웅 | 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제 |
US6897205B2 (en) * | 2001-01-31 | 2005-05-24 | Roehm Gmbh & Co. Kg | Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
ITMI20012572A1 (it) * | 2001-12-06 | 2003-06-06 | Istituto Biochimico Italiano | Microgranuli di acido ursodesossicolico |
US7145125B2 (en) * | 2003-06-23 | 2006-12-05 | Advanced Optical Technologies, Llc | Integrating chamber cone light using LED sources |
TW200533391A (en) * | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
JP2008511651A (ja) * | 2004-08-30 | 2008-04-17 | セオ ホン ユー | 局所虚血モデルでの可溶化udcaの神経保護効果 |
KR20070084211A (ko) * | 2004-10-15 | 2007-08-24 | 유서홍 | 약제학적 화합물의 독성을 감소시키기 위한 방법 및 조성물 |
KR101358078B1 (ko) * | 2004-11-01 | 2014-02-06 | 주식회사 유스팜인터내셔널 | 근위축성 측삭 경화증의 신경퇴행을 감소시키기 위한 방법및 조성물 |
CA2744697C (en) * | 2008-11-26 | 2016-06-21 | Satiogen Pharmaceuticals, Inc. | Use of compositions comprising bile acids, salts, and mimics thereof for the treatment of obesity or diabetes |
JP2012509891A (ja) | 2008-11-26 | 2012-04-26 | サティオゲン ファーマシューティカルズ,インク. | 肥満症及び糖尿病を治療するための胆汁酸再循環阻害剤 |
US9006288B2 (en) | 2009-01-12 | 2015-04-14 | Biokier, Inc. | Composition and method for treatment of diabetes |
KR20170034928A (ko) * | 2009-01-12 | 2017-03-29 | 바이오키어 인코포레이티드 | 당뇨병 치료 조성물 및 치료방법 |
US9314444B2 (en) | 2009-01-12 | 2016-04-19 | Biokier, Inc. | Composition and method for treatment of NASH |
BR112012006437A2 (pt) | 2009-09-23 | 2016-04-19 | Biokier Inc | composições e métodos para tratamento do diabetes e outros distúrbios |
WO2011075539A2 (en) * | 2009-12-18 | 2011-06-23 | Satiogen Pharmaceuticals, Inc. | Treatment of obesity or diabetes with bile acid sequestrants |
WO2011150286A2 (en) | 2010-05-26 | 2011-12-01 | Satiogen Pharmaceuticals,Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
JP6217938B2 (ja) | 2011-10-28 | 2017-10-25 | ルメナ ファーマシューティカルズ エルエルシー | 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤 |
WO2015142178A1 (en) | 2014-03-20 | 2015-09-24 | Disphar International B.V. | Bile acid composition with enhanced solubility |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2340060A1 (de) * | 1973-08-08 | 1975-02-20 | Scherer Gmbh R P | Magensaftresistente gelatinekapseln und verfahren zu deren herstellung |
FR2358144A1 (fr) * | 1976-07-13 | 1978-02-10 | Lipha | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire |
IT1101649B (it) * | 1978-12-15 | 1985-10-07 | Lehner Ag | Composizione farmaceutica ad azione prolungata contenente acidi biliari |
IL68769A (en) * | 1983-05-23 | 1986-02-28 | Hadassah Med Org | Pharmaceutical compositions containing insulin for oral administration |
AT389308B (de) * | 1984-12-12 | 1989-11-27 | Medica Pharma Co Ltd | Verfahren zur herstellung von neuem haeminarginat bzw. haeminlysinat |
GB2189699A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
IT1197038B (it) * | 1986-08-01 | 1988-11-25 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
IT1212141B (it) * | 1987-06-03 | 1989-11-08 | So Ri Far S R L | Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare. |
YU183988A (en) * | 1988-09-30 | 1990-08-31 | Lek Tovarna Farmacevtskih | Process for preparing dispersion pills of dihydroergotoxine |
-
1991
- 1991-04-12 IT ITBO910113A patent/IT1245890B/it active IP Right Grant
-
1992
- 1992-04-01 US US07/861,466 patent/US5380533A/en not_active Expired - Lifetime
- 1992-04-02 DE DE69212879T patent/DE69212879T2/de not_active Expired - Fee Related
- 1992-04-02 ES ES92105716T patent/ES2090395T3/es not_active Expired - Lifetime
- 1992-04-02 EP EP92105716A patent/EP0509335B1/de not_active Expired - Lifetime
- 1992-04-10 CA CA002065773A patent/CA2065773C/en not_active Expired - Fee Related
- 1992-04-10 JP JP4091130A patent/JP2509045B2/ja not_active Expired - Fee Related
- 1992-04-11 KR KR1019920006052A patent/KR970005176B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5380533A (en) | 1995-01-10 |
ITBO910113A1 (it) | 1992-10-12 |
DE69212879T2 (de) | 1997-01-23 |
IT1245890B (it) | 1994-10-25 |
EP0509335B1 (de) | 1996-08-21 |
ES2090395T3 (es) | 1996-10-16 |
CA2065773C (en) | 1999-01-26 |
ITBO910113A0 (it) | 1991-04-12 |
JP2509045B2 (ja) | 1996-06-19 |
JPH0597676A (ja) | 1993-04-20 |
EP0509335A1 (de) | 1992-10-21 |
CA2065773A1 (en) | 1992-10-13 |
KR970005176B1 (ko) | 1997-04-14 |
KR920019359A (ko) | 1992-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69212879D1 (de) | Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren | |
DE69212882D1 (de) | Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung | |
IS3957A (is) | Aðferð til framleiðslu á þrýstingsúðasamsetningumtil inntöku lyfja með innöndun | |
ATE203400T1 (de) | Pharmazeutische formulierungen | |
DK362189D0 (da) | Farmaceutisk praeparat til intravenoes indgift | |
DE69613463D1 (de) | Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung | |
DE122004000023I2 (de) | Pharmazeutische Zusammensetzung | |
DK481989A (da) | Farmaceutiske formuleringer | |
DK0515312T3 (da) | Farmaceutisk præparat | |
ATA129892A (de) | Pharmazeutische zusammensetzung | |
DE68900994D1 (de) | Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe. | |
DE4291156T1 (de) | Verbesserte pharmazeutische Zusammensetzungen | |
DK385488A (da) | Farmaceutisk praeparat indeholdende somatostatinanaloge | |
ITMI921123A0 (it) | Formulazioni farmaceutiche orali contenenti antocianosidi | |
EE03744B1 (et) | Valproehapet sisaldavad farmatseutilised mikrokerakesed oraalseks manustamiseks | |
ITTO920303A0 (it) | "composizione farmaceutica antiinfiammatoria" | |
IT9019112A1 (it) | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina | |
MX9200146A (es) | Composiciones farmaceuticas deglutibles | |
IT1223343B (it) | Formulazioni farmaceutiche per somministrazione transdermica | |
NO951933D0 (no) | Farmasöytiske formuleringer av ibuprofen | |
ATA133288A (de) | Pharmazeutische zusammensetzung | |
ITMI913510A0 (it) | Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita' | |
MX9205454A (es) | Composicion farmaceutica para administracion oral al tracto gastrointestinal que comprende calcitonina | |
IT9021021A0 (it) | Composizioni farmaceutiche per la somministrazione orale di irudina | |
IT1223132B (it) | Composizione farmaceutica per somministrazione nasale |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |